# Erythropoietin and Platelet Activation Markers

> **NCT01392612** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 12 (actual)

## Conditions studied

- Thrombosis
- Hypertension

## Interventions

- **DRUG:** erythropoietin

## Key facts

- **NCT ID:** NCT01392612
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-02
- **Final completion:** 2007-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2011-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01392612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01392612, "Erythropoietin and Platelet Activation Markers". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT01392612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*